Rituximab for acute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation: a case report

2020 
ABSTRACTAcute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation (HSCT) is rare, and the exact pathogenesis remains unclear. Here, we report the case of a 20-year-old...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    20
    References
    1
    Citations
    NaN
    KQI
    []